Science News
from research organizations

High-dose Ibuprofen May Slow Cystic Fibrosis Lung Disease -- Especially In Children

Date:
October 18, 2007
Source:
John Wiley & Sons, Inc.
Summary:
The most important clinical problem for people with cystic fibrosis is inflammation of their lungs. The inflammation then plays a role in further damaging the tissues. Consequently, people have wondered whether giving non-steroidal anti-inflammatory drugs (NSAIDs) to patients with CF will reduce lung inflammation. Long-term high-dose ibuprofen may slow the rate of decline in lung function in children with cystic fibrosis when treatment is started under the age of 13.
Share:
         
Total shares:  
FULL STORY

The most important clinical problem for people with cystic fibrosis (CF) is inflammation of their lungs. The inflammation then plays a role in further damaging the tissues. Consequently, people have wondered whether giving non-steroidal anti-inflammatory drugs (NSAIDs) to patients with CF will reduce lung inflammation.

This updated Cochrane Review supports the intriguing suggestion that long-term high-dose ibuprofen slows the rate of decline in lung function in children when treatment is started under the age of 13.

The Review now includes new data from a large Canadian multi-centre study, which doubled the number of participants that the researchers could analyse, and in particular, added a large number of children. "The results now show that high-dose ibuprofen may slow down the rate at which the lung function of a child with CF deteriorates. By slowing the rate of deterioration, high-dose ibuprofen can contribute to longer and healthier lives for children with Cystic Fibrosis," said lead researcher Dr Larry Lands, who works in the Department of Pediatrics at Montreal Children's Hospital.

"High-dose ibuprofen, a relatively inexpensive treatment, requires medical supervision, but is generally well-tolerated. Further work is ongoing in my laboratory on the mechanisms of action of high-dose ibuprofen, so that more targeted and potent therapies can be developed," said Lands.

The long-term effects of prolonged use of high doses of NSAIDs have yet to be determined. This treatment is not currently recommended for routine use and patients receiving the therapy should do so under the supervision of a specialist CF Centre. However, future research could lead to real improvements in patients' lives.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "High-dose Ibuprofen May Slow Cystic Fibrosis Lung Disease -- Especially In Children." ScienceDaily. ScienceDaily, 18 October 2007. <www.sciencedaily.com/releases/2007/10/071016195927.htm>.
John Wiley & Sons, Inc.. (2007, October 18). High-dose Ibuprofen May Slow Cystic Fibrosis Lung Disease -- Especially In Children. ScienceDaily. Retrieved April 27, 2015 from www.sciencedaily.com/releases/2007/10/071016195927.htm
John Wiley & Sons, Inc.. "High-dose Ibuprofen May Slow Cystic Fibrosis Lung Disease -- Especially In Children." ScienceDaily. www.sciencedaily.com/releases/2007/10/071016195927.htm (accessed April 27, 2015).

Share This Page:


Health & Medicine News
April 27, 2015

Latest Headlines
updated 12:56 pm ET